Yes the ops move gives less risk to the sp, and makes the company more attractive as a T/O also makes it more attractive to Board purchasing stock prior to an announcement!
Trial results have had a high degree of variability thats very true and have bee done on to small a sample IMHO but the nano market cap is small for a company at this stage of devpt
They should not worry about FDA approval instead go the European route dueto the plant based product liked by German pharmacies
I would be hesitant about holding too much in this as it is extremely speculative so many wonder cancer treatment companies out there!
- Forums
- ASX - By Stock
- SBP
- agm today
SBP
solbec pharmaceuticals limited
agm today, page-9
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NRZ
NEURIZER LTD
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online